Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832.SZ)
CNY 51.75
(0.27%)
CNY 51.75
(0.27%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 916.78 Million CNY | 9.23% |
| 2022 | 839.32 Million CNY | 30.05% |
| 2021 | 645.37 Million CNY | 40.52% |
| 2020 | 459.28 Million CNY | 93.98% |
| 2019 | 236.77 Million CNY | 21.79% |
| 2018 | 194.41 Million CNY | 35.87% |
| 2017 | 143.08 Million CNY | 17.66% |
| 2016 | 121.61 Million CNY | 7.62% |
| 2015 | 113 Million CNY | 26.6% |
| 2014 | 89.25 Million CNY | 18.22% |
| 2013 | 75.49 Million CNY | -6.87% |
| 2012 | 81.07 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 953.2 Million CNY | 3.97% |
| 2024 Q3 | 996.3 Million CNY | 5.82% |
| 2024 Q2 | 941.5 Million CNY | -1.23% |
| 2023 Q4 | 916.78 Million CNY | 0.24% |
| 2023 Q3 | 914.55 Million CNY | 2.79% |
| 2023 Q2 | 889.77 Million CNY | 4.73% |
| 2023 FY | 916.78 Million CNY | 9.23% |
| 2023 Q1 | 849.54 Million CNY | 1.22% |
| 2022 Q3 | 790.13 Million CNY | 7.23% |
| 2022 Q2 | 736.83 Million CNY | 9.46% |
| 2022 FY | 839.32 Million CNY | 30.05% |
| 2022 Q1 | 673.15 Million CNY | 4.3% |
| 2022 Q4 | 839.32 Million CNY | 6.23% |
| 2021 Q1 | 504.72 Million CNY | 9.89% |
| 2021 Q2 | 581.1 Million CNY | 15.13% |
| 2021 Q3 | 641.33 Million CNY | 10.36% |
| 2021 Q4 | 645.37 Million CNY | 0.63% |
| 2021 FY | 645.37 Million CNY | 40.52% |
| 2020 FY | 459.28 Million CNY | 93.98% |
| 2020 Q2 | 393.75 Million CNY | 44.23% |
| 2020 Q3 | 451 Million CNY | 14.54% |
| 2020 Q4 | 459.28 Million CNY | 1.84% |
| 2020 Q1 | 272.99 Million CNY | 15.3% |
| 2019 FY | 236.77 Million CNY | 21.79% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 Q4 | 236.77 Million CNY | 0.0% |
| 2018 FY | 194.41 Million CNY | 35.87% |
| 2017 Q4 | 143.08 Million CNY | 0.0% |
| 2017 FY | 143.08 Million CNY | 17.66% |
| 2017 Q2 | 148.74 Million CNY | 0.0% |
| 2016 Q2 | 140.24 Million CNY | 0.0% |
| 2016 Q1 | 140.24 Million CNY | 24.11% |
| 2016 FY | 121.61 Million CNY | 7.62% |
| 2016 Q3 | 121.61 Million CNY | -13.29% |
| 2016 Q4 | 121.61 Million CNY | 0.0% |
| 2015 Q1 | 106.84 Million CNY | 19.7% |
| 2015 FY | 113 Million CNY | 26.6% |
| 2015 Q4 | 113 Million CNY | 0.0% |
| 2015 Q3 | 113 Million CNY | 5.77% |
| 2015 Q2 | 106.84 Million CNY | 0.0% |
| 2014 Q2 | 91.49 Million CNY | 0.0% |
| 2014 Q3 | 89.25 Million CNY | -2.45% |
| 2014 Q1 | 91.49 Million CNY | 21.19% |
| 2014 Q4 | 89.25 Million CNY | 0.0% |
| 2014 FY | 89.25 Million CNY | 18.22% |
| 2013 FY | 75.49 Million CNY | -6.87% |
| 2013 Q1 | - CNY | 0.0% |
| 2013 Q4 | 75.49 Million CNY | 0.0% |
| 2013 Q3 | 75.49 Million CNY | 0.0% |
| 2012 FY | 81.07 Million CNY | 0.0% |